A. Meert (Brussels, Belgium), V. Westeel (Besancon, France)
p53 gene mutations in lung cancer in Korean
K. C. Shin, J. H. Chung, K. H. Lee, H. J. Park, C. H. Jeon, J. W. Park (Daegu, Gumi, Republic Of Korea)
|  |
Potentiality of detectionof microsatellite alterations in exhaled breath condensate of smokers as a tool for tumor susceptibility
G. E. Carpagnano, M. P. Foschino Barbaro, S. Tommasi, O. Resta, F. Carpagnano, G. Di Gioia, M. De Lena, A. Paradiso (Foggia, Bari, Italy)
| |
Human papilloma virus DNA in squamous cell carcinoma of upper and lower resiratory tract in Iranian patient
F. Mohammadi, M. Porabdolah, S. Sabeti, V. Bakayof, M. Shikholeslam, A. Miraesharieh, S. Karimi, Z. Mohammadtaheri, M. Masjedi (Tehran, Iraq)
| |
Tissue levels of platelet-derived endothelial cell growth factor/thymidine phosphorylase, vascular endothelial growth factor and cathepsin-D in patients with brochogenic cancer
A. A. Mohamed, N. T. Elmelegy (Assiut, Egypt)
| |
MIP-3alpha gene therapy combined with localized radiation therapy boost anti-tumor immunity in a murine model of lung carcinoma
X. Cheng, B. Zhu, G. Qian (Chongqing, China)
| |
Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients
D. Ediger, M. Koç, F. Budak, M. Karadag, H. B. Oral, E. Uzaslan, E. Ege, O. Gözü (Bursa, Turkey)
| |
Proliferative activity of non-small cell lung cancer after induction chemotherapy
O. A. Sukhoversha, I. V. Bilen‘kiy, S. M. Chekan (Dnipropetrovs‘k, Ukraine)
| |
Prognostic significance of CD-3 T-cells and NK cells in surgically treated non-small cell lung carcinomas
A. Rigas, M. Chorti, N. Trakas, N. Maouni, P. Stylianou, D. Orphanidou, A. Kotanidou, S. Legaki, F. Palamidas, N. Koulouris (Athens, Greece)
| |
Prognostic value of CD4 and CD8 T-cells in the development of lung cancer
A. Rigas, P. Stylianou, M. Chorti, N. Maouni, N. Trakas, N. Koulouris, A. Kotanidou, D. Orphanidou, P. Ziotopoulos, F. Palamidas (Athens, Greece)
| |
Serum levels of sFas and sFasL during chemotherapy of lung cancer
W. Naumnik, E. Chyczewska, T. Izycki, M. Ossolinska (Biaystok, Poland)
| |
Frequency of class I and II HLA alleles in patients with lung cancer according to responses of chemotherapy
M. Meral, I. Pirim, M. Akgun, H. Kaynar, L. Saglam, M. Gorguner, U. Yildirim (Erzurum, Turkey)
| |
A serum level of IGF-I and IGFBP-3 in patients with lung cancer during chemotherapy
T. Izycki, E. Chyczewska, W. Naumnik, M. Ossolinska (Bialystok, Poland)
| |
The levels of cathepsin K (Cat K) in serum during chemotherapy of lung cancer
W. Naumnik, E. Chyczewska, T. Izycki, M. Ossolinska (Biaystok, Poland)
| |
Helicobacter pylori presence in bronchoscopic biopsy specimens in lung cancer
A. Gur, N. D. Bakan, G. Ozkan, D. Kanmaz, R. Kendirlinan, M. Bayram, G. Camsari (Istanbul, Turkey)
| |
Investigation of H. pylori presence via PCR, culturing and hystopathologic methods in bronchial lavage and biopsy specimens of patients with lung cancer
A. Pinar, E. Tabakoglu, O. N. Hatipoglu, T. Caglar, M. Otkun, S. Altaner (Edirne, Turkey)
| |
Expression of apoptosis gene related protein in thymoma and invasive thymoma
F. Mohammadi, Z. Mohammadtaheri, S. Karimi, A. Mirafsharieh, A. Abbasi Dezfouli, K. Khodad, M. Bahadori (Tehran, Islamic Republic Of Iran)
| |
Vascular endothelial growth factor in sera of patients with non-small cell lung cancer
I. Porebska, E. Passowicz-Muszynska, R. Jankowska (Wrocaw, Poland)
| |
The role of iron and transferrin serum levels in lung cancer patients - a single institution experience
T. Radjenovic-Petkovic, D. Nastasijevic-Borovac, T. Pejcic, M. M. Radovic, I. Djordjevic (Nis, Serbia And Montenegro)
| |
Diagnostic value of telomerase activity measurement in transthoracic fine needle biopsy (FNB) specimens of non-small cell lung cancer
T. Targowski, K. Jahnz-Rozyk, T. Szkoda, S. From, R. Rozynska, T. Plusa (Warsaw, Poland)
| |
Heat shock protein (HSP) 72 polymorphism in small cell lung cancer (SCLC) patients
V. Müller, K. Rusai, A. Szabo, A. Nagy, P. Barta, P. Magyar, K. Szondy (Budapest, Hungary)
| |